The latest price target for Titan Pharma (NASDAQ:TTNP) was reported by Maxim Group on May 26, 2022. The analyst firm set a price target for $0.00 expecting TTNP to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for Titan Pharma (NASDAQ:TTNP) was provided by Maxim Group, and Titan Pharma downgraded their hold rating.

There is no last upgrade for Titan Pharma

The last downgrade for Titan Pharmaceuticals Inc happened on May 26, 2022 when Maxim Group changed their price target from N/A to N/A for Titan Pharmaceuticals Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Titan Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Titan Pharma was filed on May 26, 2022 so you should expect the next rating to be made available sometime around May 26, 2023.

While ratings are subjective and will change, the latest Titan Pharma (TTNP) rating was a downgraded with a price target of $0.00 to $0.00. The current price Titan Pharma (TTNP) is trading at is $6.06, which is out of the analyst’s predicted range.